Elsevier

Cancer Epidemiology

Volume 39, Supplement 1, December 2015, Pages S1-S10
Cancer Epidemiology

European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk

https://doi.org/10.1016/j.canep.2015.05.009Get rights and content
Under a Creative Commons license
open access

Abstract

This overview describes the principles of the 4th edition of the European Code against Cancer and provides an introduction to the 12 recommendations to reduce cancer risk. Among the 504.6 million inhabitants of the member states of the European Union (EU28), there are annually 2.64 million new cancer cases and 1.28 million deaths from cancer. It is estimated that this cancer burden could be reduced by up to one half if scientific knowledge on causes of cancer could be translated into successful prevention. The Code is a preventive tool aimed to reduce the cancer burden by informing people how to avoid or reduce carcinogenic exposures, adopt behaviours to reduce the cancer risk, or to participate in organised intervention programmes. The Code should also form a base to guide national health policies in cancer prevention. The 12 recommendations are: not smoking or using other tobacco products; avoiding second-hand smoke; being a healthy body weight; encouraging physical activity; having a healthy diet; limiting alcohol consumption, with not drinking alcohol being better for cancer prevention; avoiding too much exposure to ultraviolet radiation; avoiding cancer-causing agents at the workplace; reducing exposure to high levels of radon; encouraging breastfeeding; limiting the use of hormone replacement therapy; participating in organised vaccination programmes against hepatitis B for newborns and human papillomavirus for girls; and participating in organised screening programmes for bowel cancer, breast cancer, and cervical cancer.

Keywords

Cancer prevention
Cancer risk factors
Cancer screening
Europe

Abbreviations

DG SANTE
Directorate-General for Health and Food Safety
EC
European Commission
EU
European Union
HPV
human papilloma virus
HBV
hepatitis B virus
HIV
human immunodeficiency virus
HRT
hormone replacement therapy
IARC
International Agency for Research on Cancer
PICOS
Population, Intervention, Control, Outcome, Study design
UK
United Kingdom
UV
ultraviolet
UVR
ultraviolet radiation
WG
working group
WCRF/AICR
World Cancer Research Fund/American Institute of Cancer Research
WHO
World Health Organization

Cited by (0)

This is an Open Access article published under the CC BY NC ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that IARC endorses any specific organisation, products or services. The use of the IARC logo is not permitted. This notice should be preserved along with the article's original URL.

1

Members of the Scientific Secretariat and/or Chairs of Expert Working Groups (as shown in Fig. 2).

2

Members of the European Code against Cancer Scientific Committee.